PPD has appointed Louis Renzetti, Ph.D., vice president of strategic laboratory operations. “Lou brings strong pharmaceutical expertise to help us build and strengthen our strategic lab partnerships with pharma, biotech, academia and government clients,” said Lee Babiss, Ph.D., PPD’s executive vice president of global lab services and chief scientific officer. “His leadership will be instrumental as we continue implementing innovative new strategies to integrate our laboratory and Phase I services with our Phase II-IV services to provide clients with end-to-end, value-chain capabilities.”

Dr. Renzetti has more than 20 years of experience in drug discovery as a pharmacologist, drug development specialist and therapeutic area leader. Prior to joining the company, Dr. Renzetti served at Roche in a series of senior leadership positions, most recently as vice president and global head of the RNA therapeutics division, where he led the company’s efforts to advance a therapeutic platform to treat severe diseases such as cancer.